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ABSTRACT. This study examined depressive symptoms in 475 pa-
tients with cancer and in a reference group of 255 individuals without
cancer from the general population and the associations of those symp-
tomswithsociodemographicandmedicalfactors.Depressivesymptoms
were measured at 3 months (Time 1) and 15 months (Time 2) after diag-
nosis. Patients reported more depressive symptoms than the reference
group did at Times 1 and 2. Younger age, especially, was related to the
onset of depressive symptoms after a cancer diagnosis. Better-educated
patients and those with a lower stage of disease reported a greater de-
creaseindepressivesymptomsovertime.Theauthorsconcludethatcer-
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A diagnosis of cancer, its prolonged treatment, and physical side ef-
fects can have a profound impact on patients’ lives. The sudden con-
frontation with such a life-threatening disease may disrupt their emotional
balance and induce feelings of uncertainty, a diminished self-image,
andchangesinrelationshipswithfamilyandfriends(Moos&Schaefer,
1984). Not surprisingly, depressive symptoms are the most frequently
encountered psychological problem among the medically ill, including
cancer patients (Grassi et al., 2000; Katon & Sullivan, 1990).
REVIEW OF THE LITERATURE
The recognition and treatment of depressive symptoms in cancer pa-
tients is of crucial importance because these symptoms may adversely
affect their quality of life, compliance with treatment, length of hospi-
talization, ability to care for themselves, and perhaps even progression
of the disease (McDaniel et al., 1995). However, the recognition of de-
pressive symptoms in cancer patients is often hampered for several rea-
sons(Katholetal.,1990a,1990b).First,depressivesymptomsareoften
an appropriate and normal reaction to a life-threatening event, such as a
cancer diagnosis. In addition, somatic symptoms of depression, such as
fatigue, weight loss, and sleep problems, may resemble symptoms of
cancer or the side effects of treatment. Patients also may have difficulty
disclosing emotional problems to their physician or nurses, and physi-
ciansandnursesmaybereluctantandlackthetimeandcommunication
skills to probe into patients’ psychological problems (Maguire et al.,
1980).
Information about the risk factors related to an increased vulnerabil-
ity to depressive symptoms may facilitate early recognition, monitor-
ing, and treatment of high-risk patients (Sheard & Maguire, 1999).
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demographic factors (e.g., gender, age, education, and marital status)
and medical factors (e.g., cancer site, stage, and type of treatment)
(Breitbart, 1995; Jacobsen et al., 1998; Moos & Schaefer, 1984; van’t
Spijker, Trijsburg, & Duivenvoorden, 1997). Because these factors are
known at diagnosis and are unlikely to be modifiable, they may be par-
ticularly useful markers for identifying patients at high risk for depres-
sive symptoms.
In the initial period after diagnosis, approximately one-fourth (24%)
of cancer patients report depressive symptoms, although the rates of
these symptoms vary widely–from 1% to 50% (McDaniel et al., 1995).
Over time, a number of studies found a decrease in depressive symptoms
in the year after diagnosis (Chaturvedi & Maguire, 1998; Fallowfield et
al., 1990; Goldberg et al., 1992; Nordin & Glimelius, 1999), whereas
other studies found no significant decrease in depressive symptoms
over time (Omne-Ponten et al., 1992; Vinokur et al., 1990). Further-
more, a significant minority of cancer patients, ranging from 15% to
30%,apparentlycontinuestoexperiencedepressivesymptomsoneyear
afterdiagnosis(Fallowfieldetal.,1990;Goldbergetal.,1992;Grassiet
al., 1997). Interpreting the variability in the results about the presence
and course of depressive symptoms is difficult because the studies vary
by medical factors (e.g., site, stage, treatment, hospitalization status,
time since diagnosis), study cohort (e.g., gender, age), definition of de-
pression (syndrome versus symptom), and diagnostic method (self-report
versus interview) (DeFlorio & Massie, 1995; McDaniel & Nemeroff,
1993). Nevertheless, the studies clearly demonstrate that depressive
symptoms are common among recently diagnosed cancer patients.
Limitation of Previous Studies
A limitation of most previous studies on depressive symptoms among
cancer patients is the lack of a reference group of individuals without
cancer from the general population. The inclusion of such a reference
group is needed to examine the magnitude of depressive symptoms
among patients, taking into account the fact that depressive symptoms
also are prevalent in the general population (Blazer et al., 1994).
Afewstudiesincludedareferencegroupofindividualsfromthegen-
eral population, but the results were inconsistent. Dean (1987) found
that cancer patients were significantly more depressed than controls
were, whereas Groenvold et al. (1999) found that the proportion of
cases of depression in patients and controls was not significantly differ-
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among cancer patients, van’t Spijker, Trijsburg, and Duivenvoorden
(1997) found that patients were significantly more depressed in the first
months after diagnosis compared with the general population. The con-
flicting results of these studies provide only limited information about
the magnitude of depressive symptoms in response to a cancer diagno-
sis.
Little is known about the extent to which depressive symptoms in
cancer patients are the result of the diagnosis or reflect premorbid psy-
chological dysfunction. Furthermore, if patients develop depressive
symptoms as a response to the diagnosis, what happens in the year after
diagnosis,whentheyhavecompletedtreatmentandreturnedhome?Do
they continue to experience elevated levels of depressive symptoms?
Clearly, these questions need further investigation.
Sociodemographic Factors and Depressive Symptoms
Because sociodemographic factors have been related to depressive
symptoms in the general population, including such a reference group
also is useful when examining the role of sociodemographic factors in
the onset and course of depressive symptoms after a diagnosis of can-
cer. In general, women, people between the ages of 20 and 50, people
with less education, and people who are separated, divorced, or wid-
owed are more prone to develop depressive symptoms than are their
counterparts (Adler et al., 1994; Bebbington et al., 1998; Blazer et al.,
1994; Kaplan, Sadock, & Grebb, 1994). Therefore, it is not surprising
that sociodemographic factors also have been associated with depres-
sive symptoms in cancer patients. For instance, several studies found
that female patients reported similar or higher levels of depressive
symptoms than male patients did (Baider, Perez, & De-Nour, 1989;
DeFlorio&Massie,1995;Greimel,Padilla,&Grant,1998;Liangetal.,
1990; Rodrigue, 1994). Furthermore, younger patients seemed to expe-
rience more depressive symptoms and psychological problems than
older patients did (Compas et al., 1999; Pasacreta, 1997; Vinokur et al.,
1990;Wenzeletal.,1999).However,afewstudiesfailedtofindthisre-
lationship between age and depressive symptoms (Derogatis et al.,
1983; Maunsell, Brisson, & Deschenes, 1992; Rodrigue, 1994).
Interestingly, in contrast to findings in the general population, level of
education and marital status seemed to be weakly related to depressive
symptomsincancerpatientsduringtheinitialperiodafterdiagnosisand
oneyearlater(Maunsell,Brisson,&Deschenes,1992;Omne-Pontenet
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to buffer cancer patients against the negative consequences of the diag-
nosis. Because most previous studies lacked a reference group from the
general population, little is known about whether certain sociodemo-
graphic factors place people at a higher risk for developing depressive
symptomsafteracancerdiagnosisorwhethersuchfactorsprimarilyre-
flect morbidity in the general population.
Medical Factors and Depressive Symptoms
Therelationshipbetweenmedicalfactors,suchascancersite,stage,and
treatment, and depressive symptoms also has been examined frequently
(e.g., Loge et al., 1997; van’t Spijker, Trijsburg, & Duivenvoorden,
1997). For instance, patients with certain cancers (e.g., pancreatic can-
cer) have reported elevated levels of depressive symptoms compared
with patients with breast, colon, and gynecological cancers (McDaniel
et al., 1995; Newport & Nemeroff, 1998). However, Given, Given, and
Stommel (1994) found no significant differences in depressive symp-
tomsamongpatientswithbreast,colon,gynecologic,prostate,andlung
cancers and lymphoma.
Regarding stage of disease, most studies did not find elevated levels
of psychological distress among patients with advanced disease in the
first year after diagnosis, compared with patients with earlier-stage dis-
ease (Ell et al., 1989; Hoskins, 1997; Maunsell et al., 1992). Regarding
treatment, patients treated with chemotherapy reported elevated levels
of depressive symptoms in the first months after diagnosis (Hoskins,
1997; Maguire et al., 1980). However, Pasacreta (1997) found no sig-
nificant difference in depressive symptoms between patients treated
with or without chemotherapy.
Patients’ medical characteristics are likely to be strongly related to
their sociodemographic characteristics (Coebergh, Van der Heijden, &
Janssen-Heijnen,1995;Schaapveld&Otter,1998).Forinstance,breast
cancerisfoundprimarilyinfemalepatientsandoftenisdiagnosedatan
earlier age (age 45 to 75 years) than is colorectal cancer, for example
(age60yearsorolder).Thesestronginterrelationshipsmaycauseprob-
lemswhenattemptingtointerprettheassociationsofsociodemographic
andmedicalfactorswithdepressivesymptoms.Forinstance,whenare-
lationshipisfoundbetweengenderanddepressivesymptoms,itmaybe
confounded by age and site. Most studies of cancer patients have not
systematicallyexaminedbothsociodemographicandmedicalfactorsin
relation to depressive symptoms (Ford, Lewis, & Fallowfield, 1995).
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toms after a cancer diagnosis, we conducted a longitudinal study in a
large group of newly diagnosed cancer patients and an age-and gen-
der-matched reference group of people without cancer from the general
population. The goals of the study were fourfold:
• to examine the extent to which cancer patients reported more de-
pressive symptoms at 3 and 15 months after diagnosis than did
members of the reference group,
• to explore the relationships between the sociodemographic factors
and the presence and course of depressive symptoms in patients
and references and differences in these associations between the
two groups,
• to explore the relationships between the medical factors and the
presence and course of depressive symptoms in patients, and
• to examine the interrelationships among the medical and socio-
demographic factors and whether sociodemographic and medical
factors were independently related to the presence and course of
depressive symptoms in patients.
METHODS
Procedures
The data for the present study were collected as part of a longitudinal
study on the quality of life of cancer patients in the year after diagnosis
(De Ruiter, 1995). Patients were recruited from 12 hospitals in the
northern part of The Netherlands with the assistance of the Dutch Can-
cer Registration of the Comprehensive Cancer Centre North Nether-
lands. Patients were selected on the basis of site and stage of disease.
The criteria for inclusion in the study were as follows: (1) age 18 years
or older, (2) newly diagnosed with cancer, (3) no distant metastases,
(4) a life expectancy of at least one year, and (5) informed about the
diagnosis. A letter containing information about the project and a par-
ticipation form were attached to the eligible patients’ medical records,
andthepatients’physiciansapproachedthemregardingparticipationin
thestudy.Patientswhoagreedtoparticipatewereinterviewedandfilled
out a questionnaire at three points: 3 months, 9 months, and 15 months
after diagnosis.
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fices of five townships in which the patients lived. These people were
matched at the group level on age and gender with the patient group.
They also were interviewed and completed the questionnaire at the
same intervals as the patients.
Inthepresentstudy,wefocusedontheinterviewsat3and15months
after diagnosis, hereafter labeled Time 1 and Time 2. These two points
in the course of the illness are believed to capture the period of crisis
(3 months) and short-term adjustment to cancer (15 months).
Over a period of two years, 516 patients returned the participation
form.Becausethenumberofpatientswhoactuallyreceivedaparticipa-
tionformfromtheirphysicianwasnotregisteredconsistently,informa-
tion on the exact response rate is not available. At Time 1, 475 of the
516 patients (92%) entered the study; at Time 2, 403 of the 475 patients
(85%) participated. The main reasons for dropping out after submitting
the participation form were serious illness and death.
According to the distribution of gender and age in the patient group,
559 reference individuals were selected and received a participation
form.AtTime1,255ofthem(46%)enteredthestudy;atTime2,225of
the255(88%)participated.Themainreasonsfordroppingoutwereun-
willingness to participate, inability to find them, or incomplete ques-
tionnaire data.
In the analyses of the present study, we only included patients and
referenceswhoparticipatedatbothtimeperiods.Comparisonsbetween
the patients who completed the study and those who dropped out after
Time 1 showed that patients who had lung or colorectal cancer, had
Stage III or IV disease, were treated with chemotherapy (with or with-
outsurgery)orradiotherapy(p<.01),andweremale,older,andlessed-
ucated (p < .05) were more likely to have dropped out. Obviously,
patients with a poor prognosis tended to drop out more often than other
patients did. However, we found no significant differences in the level
of depressive symptoms between patients who participated at both time
points and those who dropped out after Time 1. Comparisons between
members of the reference group who completed the study and those
who dropped out revealed no significant differences regarding socio-
demographic factors or depressive symptoms.
Measures
Depressive symptoms. The Center for Epidemiologic Studies-De-
pression (CES-D) scale is a 20-item self-report instrument of depres-
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study,weusedatotalscorebasedonthe16negativelyformulateditems
onthescale.Inapreviousstudy,wefoundthatatotalscorebasedonthe
16 negatively formulated items, excluding the 4 positively formulated
items,wasamorevalidmeasureofdepressivesymptomsinbothcancer
patients and healthy individuals (Schroevers et al., 2000). A score of 10
or higher was defined as an indicator of possible caseness of depression
(i.e., more than one standard deviation above the mean score in the ref-
erence group). In the present study, Cronbach’s alphas were .86 and .84
in the patient and reference group, respectively.
Sociodemographic and medical factors. Sociodemographic factors
(gender, age, education, and marital status) were collected in a semi-
structuredinterview.Fortheanalysesinthepresentstudy,weclassified
age into three groups: 18 to 44 years, 45 to 64 years, and 65 years or
older, thus making a distinction between mature adults, older adults,
and aging adults (Rowland, 1989). Education was classified into four
groups: primary, lower vocational or secondary, middle vocational or
secondary, and higher vocational or university. Marital status was
dichotomized into two groups: having a partner (i.e., married or cohab-
ited) or not having a partner (i.e., widowed, divorced, or single).
Medical data (site, stage, and treatment) were derived from the can-
cer registration from the Comprehensive Cancer Centre North Nether-
lands. According to the tumor node metastasis (TNM) classification of
malignanttumor,thestageisbasedonthetumor’ssizeandthepresence
of local or distant metastases and may range from Stage I to Stage IV
disease (Hermanek & Sobin, 1992). Because only a few patients in the
present study were diagnosed with Stage IV disease, we combined pa-
tients with Stages III and IV into one group. Treatment was classified
into the following categories: surgery only; surgery and radiotherapy;
surgery and chemotherapy; surgery, radiotherapy, and chemotherapy;
surgery and hormonal therapy, surgery, radiotherapy, and hormonal
therapy; and other (e.g., radiotherapy only).
RESULTS
Characteristics of the Sample
The characteristics of the sample are described in Table 1. The ma-
jorityofmembersofthepatientandreferencegroupswerefemale,were
less educated, and had a partner. The patients’ average age was 58.0
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57.4 years (SD = 15.2 years). Student’s t-tests indicated no significant
differencesinagebetweenthetwogroups,andPearsonchi-squareanaly-
ses revealed no significant differences in gender, education, and marital
status.
Regarding the patients’ medical characteristics, the two most impor-
tant cancers were breast cancer (47%) and colorectal cancer (27%) (see
Table2).Themajorityofpatients(89%)werediagnosedwithStageIor
II disease, indicating a relatively good prognosis. Most of them were
treated with surgery alone (48%) or surgery and radiotherapy (22%).
Presence and Course of Depressive Symptoms
To investigate our first research question, Student’s t-tests were used
to examine mean differences in depressive symptoms at Times 1 and 2
between the patient and reference groups. We used paired t-tests to ex-
amine the course of depressive symptoms over time within each group
separately. Repeated measures analysis, with the patient or reference
Schroevers, Ranchor, and Sanderman 9
TABLE 1. Sociodemographic Characteristics of the Patient and Reference
Groupsa
Characteristic Patients (n = 403) References (n = 225)
Number Percentage Number Percentage
Gender
Female 295 73 157 70
Male 108 27 68 30
Age (years)
18-44 84 21 50 22
45-64 168 42 97 43
65 or older 151 37 78 35
Marital status
Partner 310 77 172 76
No partner 92 23 53 24
Education
Primary 153 39 79 36
Lower vocational/secondary 155 39 77 35
Middle vocational/secondary 46 12 36 16
Higher vocational/university 39 10 29 13
aDifferences between the patient and reference groups were not significant (p < .05).group as a between-subjects variable and time (i.e., depressive symp-
toms at Times 1 and 2) as a within-subjects variable, were performed to
examine differences in the course of depressive symptoms between the
two groups. Mean scores of depressive symptoms in the reference
group were similar to those identified by other studies in the general
population (Bouma et al., 1995; Hann, Winter, & Jacobsen, 1999).
As Table 3 indicates, patients reported significantly more depressive
symptoms at Time 1 and Time 2 after diagnosis than members of the
reference group did (Time 1: t = 4.44, p < .001; Time 2: t = 2.93, p <
.01).1 Over time, patients showed a significant decrease in depressive
symptoms in the year after diagnosis (t = 4.19, p < .001). However, the
resultsfromtherepeatedmeasuresanalysisshowedonlyasmall,nearly
significant difference between patients and references in the course of
depressive symptoms over time (time  group, F[1,619] = 3.52, p =
.06). In other words, no significant differences between the two groups
in the course of depressive symptoms were found over time.
Atanintraindividuallevel,wefoundstrongcorrelationsbetweende-
pressive symptoms at Times 1 and 2 in patients (r = .68) and in refer-
ences (r = .55) (p < .001). Thus, there was some individual variation in
the course of depressive symptoms over time.
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TABLE 2. Medical Characteristics of the Patient Group (N = 403)
Characteristic Number Percentage
Type of cancer
Breast 189 47
Colorectal 107 27
Gynecological 62 16
Lung 29 7
Other 11 3
Stage of disease
I 165 45
II 161 44
III or IV 40 11
Initial treatment
Surgery only 195 48
Surgery and radiotherapy 88 22
Surgery and chemotherapy 29 7
Surgery, radiotherapy, and hormonal therapy 29 7
Surgery, radiotherapy, and chemotherapy 25 6
Surgery and hormonal therapy 15 4
Other 22 6The examination of the percentage of possible cases of depression,
usingPearsonchi-squareanalysis,revealedasimilarpicture.Compared
with the reference group, a significantly higher percentage of the pa-
tients was classified as having a possible case of depression at Time 1
(23% of patients versus 12% of references: χ2 = 10.43, p < .01) and at
Time2(18%ofpatientsversus10%ofreferences:χ2=7.65,p<.01).
To examine the course of possible cases of depression over time, we
determined four groups of people: (1) noncases at both Time 1 and
Time2,(2)possiblecasesatbothTime1andTime2,(3)possiblecases
at Time 1 only, and (4) possible cases at Time 2 only. The majority of
patients(71%)andreferences(83%)werenoncasesatbothtimepoints.
However,thepercentageofpossiblecasesatbothtimepointswastwice
as high among patients (11%) as among references (5%). In addition,
the percentage of possible cases at Time 1 only (thus, these people im-
proved over time) was higher among patients (11%) than among refer-
ences (7%). This finding is in line with the previous findings, which
showed a smaller number of possible cases among patients at Time 2
compared to Time 1. Finally, 7% of patients and 5% of references were
classified as possible cases of depressive symptoms at Time 2 only
(thus, these people worsened over time).
Sociodemographic Factors and Depressive Symptoms
To investigate our second research question, we used analyses of
variance (ANOVAs) to examine the relationships between sociodemo-
graphic factors and the presence of depressive symptoms in the patient
andthereferencegroupseparately.Toexaminedifferencesbetweenthe
two groups in these relationships, additional ANOVAs were performed
in the total sample, using group (patients or references), one socio-
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TABLE 3. Mean Scores of the Patient Group on the CES-D Scalea at Times 1
and 2 versus the Reference Groupb
Group Time 1 Time 2
Mean (SD) Mean (SD)
Patient group 6.09 (6.00)*** 5.17 (6.36)**
Reference group 4.13 (4.81) 3.86 (4.66)
aCenter for Epidemiologic Studies-Depression scale.
bT-test between the patient and reference groups:
**p < .01, ***p < .001.demographic factor, and the interaction of group  sociodemographic
factor as the independent factors. A significant interaction indicated
that the relationship between the sociodemographic factor and depres-
sive symptoms differed significantly for patients and references.
Gender. Gender was significantly related to depressive symptoms in
both groups, indicating that women reported significantly more depres-
sive symptoms than men did (patients at Time 1: F[1,398] = 21.18; at
Time 2: F[1,399] = 11.07; p< .001, and references at Time 1: F[1,223] =
5.10; at Time 2: F[1,221] = 4.60, p < .05). We found no significant dif-
ferences between patients and references in the relationship between
gender and depressive symptoms, as indicated by a nonsignificant
groupgenderinteractionatTimes1and2(Figure1).Thatis,acancer
diagnosis did not change the likelihood that women would report either
more or less depressive symptoms compared to men.
Age.AgewassignificantlyrelatedtodepressivesymptomsatTime1
onlyinthepatientgroup(F[2,397]=8.49,p<.001)andwasnearlysig-
nificant at Time 2 (F[2,398] = 2.88, p = .06). Pairwise comparisons
showed that patients younger than 65 years reported significantly more
12 JOURNAL OF PSYCHOSOCIAL ONCOLOGY
10
9
8
7
6
5
4
3
2
1
0
Male Female Male Female
T1 T2
D
epr
essi
v
e
sym
pt
om
s
FIGURE1.Meanscoresfordepressivesymptomsamongmaleandfemalepa-
tients andage-matchedmembersofthereferencegroupatTimes1and2.depressive symptoms than did patients aged 65 or older (p < .001). The
finding that a younger age was related to higher levels of depressive
symptoms only in the patient group was confirmed by a significant
group  age interaction in the total group at both Time 1 (group  age:
F[2,619]) = 8.08; p < .001) and Time 2 (group  age: F[2,618] = 3.31;
p < .05). As Figure 2 shows, younger patients reported more depressive
symptoms than did younger references, whereas older patients and ref-
erences reported similar levels of depressive symptoms.
Education. Education was not significantly related to depressive
symptoms in either the patient group or the reference group. We also
foundnosignificantdifferencesbetweenthetwogroupsinthisrelation-
ship between education and depressive symptoms (Figure 3).
Marital status. Marital status was significantly related to depressive
symptoms only in the reference group, showing that references without
a partner reported significantly more depressive symptoms than those
with a partner did (at Time 1: F[1,223] = 15.28, p < .001; at Time 2:
F[1,221] = 5.96; p < .05). In contrast, cancer patients with or without a
Schroevers, Ranchor, and Sanderman 13
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FIGURE 2. Mean scores for depressive symptoms at Times 1 and 2 among pa-
tients and references  in the following age groups: younger than 45 years,
45 to 64 years, and 65 years or older.partner reported similar levels of depressive symptoms. This difference
between the patient and reference groups concerning the relationship
between marital status and depressive symptoms was significant at
Time1(groupmaritalstatus:F[1,620]=4.90,p<.05).Patientswith
a partner reported more depressive symptoms than references with a
partner did, whereas patients and references without a partner reported
similar levels of depressive symptoms (Figure 4).
Multivariate analyses including all four sociodemographic factors
wereperformedtoexaminewhetherthesociodemographicfactorswere
independently related to depressive symptoms in both groups. In addi-
tion to a significant main effect of gender (F[1,594] = 10.94, p < .01)
and marital status (F[1,594] = 7.02, p < .01), we found a significant
group  age interaction on depressive symptoms at Time 1 (F[2,594] =
3.08, p < .05). At Time 2, only gender had a main effect on depressive
symptoms (F[1,593] = 6.05, p < .05).
Course of depressive symptoms. Repeated measures analyses were
performed to examine the association of each sociodemographic factor
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FIGURE 3. Mean scores for depressive symptoms at Times 1 and 2 among pa-
tients and references  with a primary education (Level 1), a lower voca-
tional or secondary education (Level 2), a middle vocational or secondary
education(Level3),andahighervocationaloruniversityeducation(Level4).with the course of depressive symptoms. No sociodemographic factor
was significantly related to the course of depressive symptoms in either
group. In the patient group, we found a nearly significant relationship
between education and the course of depressive symptoms (F[3,384] =
2.56, p = .05), indicating that patients with more education reported a
greater decrease in depressive symptoms than did less educated pa-
tients. However, a comparison of patients and references showed no
significant differences between the two groups in the relationships be-
tweenthesociodemographicfactorsandthecourseofdepressivesymp-
toms.
Patients’ Medical Factors and Depressive Symptoms
To investigate our third research question, we focused on the patient
group and used ANOVAs to examine the relationship between medical
factors and the presence of depressive symptoms (Table 4).
Cancer site. Site of the cancer was significantly related to depressive
symptomsatTime1(F[4,390]=5.77,p<.001)andTime2(F[4,391]=
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FIGURE 4. Mean scores for depressive symptoms at Times 1 and 2 among pa-
tients     and references  with or without a partner.3.65, p < .01). Pairwise comparisons showed that at Time 1, patients
with breast or gynecological cancer reported more depressive symp-
toms than patients with colorectal or lung cancer did (p < .01). At Time
2, women with breast or gynecological cancer still reported signifi-
cantly more depressive symptoms than patients with colorectal cancer
did (p < .05).
Cancer stage and treatment. Stage of disease and type of treatment
were not significantly related to depressive symptoms at either Time 1
or Time 2. There was a trend showing that certain types of treatment
(e.g., the combination of radiotherapy and chemotherapy or hormonal
therapy) were associated with relatively higher levels of depressive
symptoms (Table 4). When we used multivariate analyses that included
allthreemedicalfactors,cancersitewastheonlyfactorthatwassignifi-
cantly related to depressive symptoms at Time 1 (F[4,350] = 2.92, p <
.05) and Time 2 (F[4,352] = 2.40, p = .05).
Course of depressive symptoms. When repeated measures analyses
wereperformedtoexaminetheassociationsofeachmedicalfactorwith
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TABLE 4. Patients’ Mean Scores on the CES-Da at Times 1 and 2 According to
Type and Stage of Cancer and Its Treatment (N = 403)
Medical Characteristic Time 1 Time 2
Mean (SD) Mean (SD)
Type of cancer
Breast 7.12 (6.44) 6.15 (6.40)
Colorectal 4.40 (4.62) 3.30 (5.12)
Gynecological 7.10 (6.93) 5.42 (7.50)
Lung 3.68 (3.33) 5.10 (6.77)
Other 3.73 (4.00) 3.55 (5.97)
Stage of disease
I 5.88 (6.02) 4.44 (6.16)
II 6.31 (6.00) 5.70 (6.51)
III or IV 4.95 (4.03) 4.95(5.52)
Treatment
Surgery only 5.46 (6.58) 4.71 (6.70)
Surgery plus radiotherapy 6.66 (5.04) 4.76 (5.42)
Surgery plus chemotherapy 5.59 (4.72) 5.07 (6.72)
Surgery, radiotherapy, and hormonal therapy 8.61 (7.04) 7.00 (5.64)
Surgery, radiotherapy, and chemotherapy 7.16 (5.42) 5.92 (6.21)
Surgery and hormonal therapy 5.47 (4.60) 5.67 (6.59)
Other 5.95 (4.95) 7.36 (7.06)
aCenter for Epidemiologic Studies-Depression scale.the course of depressive symptoms, no medical factor was significantly
related to the course of depressive symptoms. However, there were
some trends indicating a small increase in depressive symptoms among
patients with lung cancer, compared to a small decrease in these symp-
toms in patients with cancer at other sites. In addition, patients with
Stage I disease and those treated with radiotherapy (with or without
chemotherapyorhormonaltherapy)reportedaslightlygreaterdecrease
in depressive symptoms than did their counterparts.
Patients’ Medical and Sociodemographic Factors
and Depressive Symptoms
As we mentioned in the review of the literature, patients’ medical
characteristicsarelikelytoberelatedtotheirsociodemographiccharac-
teristics. This section examines these relationships using chi-square
analysis. As expected, we found significant relationships among site,
stage, treatment, gender, and age (p < .001). Patients with breast (all fe-
male) or gynecological cancer had a mean age of 55 years, whereas pa-
tients with colorectal or lung cancer (the majority were male) had a
mean age of 65 years. In addition, 83% of patients with gynecological
cancer were diagnosed with Stage I disease, whereas 63% of patients
withbreastcancer,64%withcolorectalcancer,and34%withlungcan-
cer were diagnosed with Stage II disease or higher. Moreover, 83% of
the patients with colorectal cancer were treated with surgery only,
whereas 44% of patients with breast cancer and 53% with gynecological
cancer also received radiotherapy, chemotherapy, or both.
Next,weexaminedwhetherpatients’medicalandsociodemographic
factors were independently associated with the presence of depressive
symptoms. MANOVAs including all sociodemographic and medical
factors showed that only age was significantly related to depressive
symptoms at Time 1 (F[2,333], p < .01) and was nearly significant at
Time2(F[2,335],p=.06).Theseresultsareinlinewiththeearlieranal-
yses indicating that age was significantly related to depressive symp-
toms only in the patient group.
Repeated measures analysis showed that both stage of disease and
education were independently significantly related to the course of
depressive symptoms over time (cancer stage: F[2,332]; education:
F[3,332], p < .05). Pairwise comparisons showed a greater decrease in
depressive symptoms among patients with Stage I disease, compared
with those with Stage II disease or higher (p < .05). Moreover, patients
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ucation did (p < .01).
DISCUSSION
The results of the present study broaden our understanding of the
magnitude of depressive symptoms in cancer patients and the role of
sociodemographic and medical factors in several ways. First, the find-
ings showed that, as a group, cancer patients reported significantly
more depressive symptoms at 3 months after diagnosis than did a refer-
encegroupofage-matchedpeoplewithoutcancerfromthegeneralpop-
ulation.Despiteasmalldecreaseinpatients’depressivesymptomsover
time, patients continued to report significantly more depressive symp-
toms 15 months after diagnosis than did the reference group.
Second, multivariate analyses revealed that three months after diag-
nosis,agewastheonlysociodemographicfactorthatwasrelateddiffer-
ently in the patient and reference groups to the presence of depressive
symptoms. This finding suggests that in the present sample, younger
patients, especially, experienced depressive symptoms in response to a
diagnosis of cancer.
Third,medicalfactorswerenotindependentlyrelatedtothepresence
ofdepressivesymptomswhenexaminedsimultaneouslywiththesocio-
demographic factors. Fourth, we found that patients with more educa-
tion and those with early stages of cancer reported a greater decrease in
depressive symptoms over time.
The findings regarding the presence and course of depressive symp-
tomsamongthepatientsareinlinewiththefindingsinpreviousstudies
and suggest that a significant minority of cancer patients (approxi-
mately 20%) experience depressive symptoms that may persist until
one year after diagnosis and initial treatment (McDaniel et al., 1995;
Pasacreta, 1997). The findings clearly demonstrate that a diagnosis of
cancercanberegardedasalifecrisisthatmayshatterpatients’basicas-
sumptions regarding their life and future. For instance, the confronta-
tion with the multiple physical and psychosocial strains may lead to
feelings of loss regarding good physical health, independence, valued
social roles, and, more fundamentally, one’s sense of identity and the
meaning of one’s life. As a result, patients may feel depressed and lack
joy and interest in daily activities.
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The results also indicate that, at an intraindividual level, the amount
of depressive symptoms is relatively stable over time in the year after
diagnosis,particularlyamongcancerpatients.Thesefindingsareinline
with those of other studies and demonstrate the importance of the early
identification of patients at increased risk of depressive symptoms as a
response to cancer. Therefore, of particular interest is the finding that
youngerpatients,especially,reportedmoredepressivesymptomsinthe
initial period after diagnosis compared with the reference group. Other
studies also have stressed the importance of age for the adjustment to
cancer (Northouse, 1994; Pasacreta, 1997; Wenzel et al., 1999).
Younger patients seem to perceive the cancer to be a greater threat to
their lives (Vinokur et al., 1990) and to experience more intrusive thoughts
about the disease than older patients do (Epping-Jordan et al., 1999;
Wenzel et al., 1999). A possible explanation for these findings may be
that, because cancer is usually a disease of the elderly, younger patients
may anticipate it less; therefore, a diagnosis of cancer may be more dis-
ruptive and distressing to them. Thus, health care providers should
monitor possible signs of depression carefully in younger cancer pa-
tients in the initial period after diagnosis. If treatment of depression is
indicated, information about what tasks and future life goals are threat-
ened or interrupted because of the diagnosis may provide insight into
the psychological problems likely to result from the disease. That is,
younger patients particularly may be confronted with the following is-
sues: (1) uncertainty in planning the future and interruption of certain
life goals and expectations, (2) infertility or sterility, diminished attrac-
tiveness, and problems in establishing or maintaining a sexual relation-
ship, (3) a feeling of being different and isolated, facing unsatisfying
social relationships, and being concerned about the impact of the dis-
ease on the partner and children, (4) a sense of physical vulnerability,
increased dependency on others, and role reversals normally associated
with ageing, and (5) heightened introspection and reflection, which
may lead to despair about the meaningfulness of life (Rowland, 1989;
Siegel, Gluhoski, & Gorey, 1999).
Regarding the other sociodemographic factors, multivariate compar-
isons revealed no significant differences between the patient and refer-
ence groups in the associations of gender, education, and marital status
with depressive symptoms. For instance, similar to the findings by
Baider et al. (1989), we found that female patients reported more de-
pressivesymptomsthanmalepatientsdid,butthisrelationshipbetween
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ence group. These findings suggest that certain sociodemographic fac-
tors, such as gender, primarily may reflect premorbid psychological
dysfunction rather than risk factors concerning the development of de-
pressive symptoms in response to a cancer diagnosis.
These findings have certain practical implications. Apart from the
possibility of identifying patients at increased risk of experiencing de-
pressive symptoms, these findings also suggest that higher levels of
depressive symptoms in some cancer patients are not so much can-
cer-specific but instead reflect general dysfunction, to some extent at
least. Thus, for certain patients, general psychosocial care rather than
cancer-specific psychosocial interventions may be more suitable.
Apartfromtheresultsofthemultivariateanalyses,bivariateanalyses
that showed a significant difference between the patient and reference
groupsregardingtherelationshipbetweenmaritalstatusanddepressive
symptoms indicated that having a partner was related to lower levels of
depressive symptoms only in the reference group. The weak relation-
ship between marital status and depressive symptoms in the patient
group also was reported by Maunsell et al. (1992) and Omne-Ponten et
al. (1992). One possible explanation may be that confronting a diagno-
sisofalife-threateningdisease,suchascancer,maychallengetheemo-
tional stability of an intimate relationship. Having a partner may not
always or merely have beneficial effects on patients’ psychological
well-being (Manne, 1998; Penninx et al., 1998). Differences in marital
quality are likely to play an important role, with poorer relationships
conveying the same or greater risk as not being married (Coyne & An-
derson, 1999; Pistrang & Barker, 1995; Rodrigue & Park, 1996). How-
ever,whengender,age,andeducationwerecontrolledforinthepresent
study, the significant difference between the patient and reference
groups in the relationship between marital status and depressive symp-
toms disappeared. This relationship possibly was confounded by age.
Interestingly, education was not significantly related to depressive
symptoms in either group. However, patients with a higher education
reported a greater decrease in depressive symptoms over time than did
less educated patients. In other words, although cancer patients, regard-
lessofeducationallevel,showedasimilarinitialreactiontothediagno-
sis of cancer, those with more education seemed to adjust better over
time,possiblybecausetheyhadmoreadequateaccesstosocialandper-
sonal resources (e.g., social support and feelings of control, optimism,
andself-esteem)thathelpedthemcopewiththecanceranditstreatment
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tant role in recovering from depressive symptoms in cancer patients.
Role of Medical Factors
Regarding the role of medical factors in depressive symptoms, we
found that only cancer site was related to the presence of depressive
symptoms, with women with breast or gynecological cancer reporting
relatively more depressive symptoms. However, this relationship be-
tween cancer site and depressive symptoms disappeared when exam-
ined simultaneously with the sociodemographic factors.
Interestingly,althoughahigherstageofdiseasewasnotsignificantly
related to higher levels of depressive symptoms, we found that, when
examined simultaneously with sociodemographic factors, patients with
earlierstagesofdiseasereportedagreaterdecreaseindepressivesymp-
toms over time than did those with later stage disease.
Other studies also have demonstrated the overall weak relationship
between medical factors and depressive symptoms (Ell et al., 1989;
Given et al., 1994; Hoskins, 1997; Pasacreta, 1997). There are several
possible explanations for this weak relationship.
First, subjective appraisal of the stressfulness of the situation may be
more important than objective medical factors regarding the prognosis
(Dunkel-Schetter et al., 1992). Second, we cannot be certain about the
extent to which patients receive and understand medical information
about the severity of the situation and their prognosis. Third, the pres-
ence of severe physical impairment may have a stronger impact on pa-
tients’ functioning than do medical characteristics, such as treatment
(Given, Lewis, & Stommel, 1994). A large number of physical prob-
lems may lead to more concerns about a recurrence and loss of confi-
denceinone’sownbody,whichconsequentlymayleadtohigherlevels
of depressive symptoms. Finally, because most studies, including the
present study, focused on patients with a relatively good prognosis, it
may be difficult to detect a significant effect of certain medical factors,
such as advanced-stage disease or treatment with chemotherapy.
Limitations of the Study
Several limitations should be kept in mind when interpreting our re-
sults. First, it needs to be mentioned that no information was available
about how many patients did not return the participation form. Further-
more, the majority of the patients were female, less educated, living
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factors may affect the validity of the findings.
Second, the moderate number of reference-group members who re-
turned the participation form also may cause concern regarding the va-
lidity of the findings. Still, the finding that the levels of depressive
symptomsinmembersofthereferencegroupwerecomparabletolevels
in other samples of references from the general population underpins
the representativeness of our reference group. Furthermore, the present
study was the first to compare the level of depressive symptoms and its
associations with sociodemographic factors in cancer patients with an
age- and gender-matched reference group.
Third, we have made an effort to account for the strong interrelation-
ships among the sociodemographic and medical characteristics. Still,
the existence of these strong interrelationships (e.g., the overlap be-
tweengenderandcancersite)precludedrawingdefiniteconclusionsre-
garding their associations with depressive symptoms.
CONCLUSION
This study demonstrates that a diagnosis of cancer may induce de-
pressive symptoms–especially among younger patients. Additional re-
search is needed to identify other risk factors for depressive symptoms
in response to a cancer diagnosis, such as a lack of psychosocial re-
sources (e.g., low perceptions of social support, self-esteem, optimism,
and control), a past history of depression, and other coexisting stressful
life events and chronic illnesses. This information may facilitate the
early identification and monitoring of patients at increased risk for de-
veloping depressive symptoms after the diagnosis. Furthermore, psy-
chosocialinterventionstargetedatpatientsatriskmayprovetobemore
effective and able to prevent the development of severe depressive
symptoms.
NOTE
1. Using the 20-item version of the CES-D, we found the following mean scores in
the patient and reference groups, respectively: at Time 1: 9.82 and 7.79 (p < .001); at
Time 2: 9.35 and 8.26 (p = .07). Using the original cutoff point of 16 as an indicator of
possible caseness, we found the following percentages of possible cases in the patient
and reference groups, respectively: at Time 1: 18% and 10% (p < .01); at Time 2: 18%
and 12% (p = .06).
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